Skip to main content
. 2024 Oct 9;16(19):12769–12780. doi: 10.18632/aging.205707

Figure 4.

Figure 4

Bezafibrate inhibited the expression of pro-inflammatory mediators TNF-α and IL-6 against CME. (A) Plasma levels of TNF-α; (B) Plasma levels of IL-6 (n=12, **, p<0.01 vs. control group; #, ##, p<0.05, 0.01 vs. CME group).